Nabriva Therapeutics plc
USD1.42
+0.01 (+0.71%)
CEO
Colin Broom
IPO Date
2017-06-23
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
IE
Open
$1.45
Prev. Close
$1.41
Day Low
$1.35
Day High
$1.90
52W Low
$1.22
52W High
$8.45
Market Cap
$0.00B
Volume
0.71M
| 140 |
| $1.50 |
| 10 Jan 2023 | Schroeder Theodore R | Chief Executive Officer | F-InKind | Disposed | 11 | $1.30 |
| 10 Jan 2023 | Gelone Steven P. | President and COO | F-InKind | Disposed | 5 | $1.30 |
| 4 Jan 2023 | Schroeder Theodore R | Chief Executive Officer | F-InKind | Disposed | 5 | $1.89 |
| 4 Jan 2023 | Gelone Steven P. | President and COO | F-InKind | Disposed | 3 | $1.89 |
| 8 Dec 2022 | Schroeder Theodore R | Chief Executive Officer | F-InKind | Disposed | 9 | $2.02 |
| 8 Dec 2022 | Gelone Steven P. | President and COO | F-InKind | Disposed | 4 | $2.02 |
| 2 Dec 2022 | Schroeder Theodore R | Chief Executive Officer | F-InKind | Disposed | 5 | $2.25 |
| 2 Dec 2022 | Gelone Steven P. | President and COO | F-InKind | Disposed | 3 | $2.25 |